- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00760721
Increasing Hepatitis B Screening Among Korean Church Attendees
Increasing Hepatitis B Screening Among Korean Church Attendees (Component Project) Program Project Title: Liver Cancer Control Interventions for Asian Americans
The purpose of this study is to design an intervention to increase hepatitis B (HBV) screening among Korean Americans.
The investigators will design a culturally specific intervention (educational sessions) and test the effect of the intervention on 1200 Korean Americans.
All subjects will be interviewed before the intervention/control sessions and 6 months after the sessions to assess HBV screening levels in the two groups. Self-reported HBV screening will be verified by a review of subjects' medical records.
The primary study hypothesis is that the intervention group will have a higher rate of HBV serologic testing at follow-up compared to the control group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to design an intervention to increase hepatitis B (HBV) screening among Korean Americans.
The investigators will design a culturally specific intervention; an educational small group discussion led by a trained Korean leader. The effect of the intervention will be tested on 1200 Korean Americans.
Subjects will be recruited at Korean churches and invited to join a one-hour discussion of health issues with other members of their church. One half of the subjects will participate in the intervention group. These subjects will discuss HBV and will receive resources related to HBV and where to obtain screening. The other half of the subjects will participate in the control group. These subjects will discuss nutrition and physical activity and will receive resources related to these topics, but not related to HBV and where to obtain screening.
All subjects will be interviewed before the sessions and 6 months after the sessions to assess HBV screening levels in the two groups. Self-reported HBV screening will be verified by a review of subjects' medical records.
The primary study hypothesis is that the intervention group will have a higher rate of HBV serologic testing at follow-up compared to the control group.
Secondary hypotheses are:
The intervention group will have a higher level of knowledge of hepatitis B and liver cancer at follow-up compared to the control group.
The effect of the intervention on hepatitis B serologic testing will be mediated by knowledge of hepatitis B and liver cancer.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA, Division of Cancer Prevenion and Control Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Korean ancestry
- Have not previously received HBV screening or do not know the results of previous HBV screening test
- No history of liver cancer or liver disease
- Current resident of the Los Angeles area
Exclusion Criteria:
- Younger than 18 years of age or Older than 64 years of age
- Not of Korean ancestry
- Previously screened for HBV
- History of liver disease or liver cancer
- Not a current resident of the Los Angeles area
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SCREENING
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: 1
Educational small group session with HBV screening resources provided
|
1 hour small group health-related discussion
|
|
SHAM_COMPARATOR: 2
Educational small group discussion, diet/physical activity resources provided
|
1 hour small group health-related discussion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Obtaining HBV Screening Test
Time Frame: 6 months post-intervention
|
6 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Knowledge and Attitudes Regarding HBV Screening
Time Frame: 6 months post-intervention
|
6 months post-intervention
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P01CA109091-01A1 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.